Skip to main content

Table 1 Antibodies used

From: Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases

Name of antibody Protein target Manufacturer Catalog Dilution used
CK7 Cytokeratin 7 Fuzhou Maixin Biotech Kit-0021 1:1
P504S alpha-methylacyl-CoA racemase (AMACR), P504S Fuzhou Maixin Biotech RMA-0546 1:1
WT-1 Wilms tumor 1 Fuzhou Maixin Biotech MAB-0678 1:1
CD57 human natural killer-1 Fuzhou Maixin Biotech MAB-0257 1:1
P53 p53 Fuzhou Maixin Biotech MAB-0674 1:1
BCL2 B-cell lymphoma 2 Fuzhou Maixin Biotech RMA-0660 1:1
CCND1 Cyclin-D1 Abcam ab16663 1:200
P16 P16INK4A Fuzhou Maixin Biotech MAB-0673 1:1
p-ERK phosphorylated Thr202/Tyr204-p44/42 MAPK Cell Signaling Tech 4370 1:100
ERK total p44/42 MAPK Cell Signaling Tech 4695 1:100
p-MEK phosphorylated MEK1/2 (Ser221) Cell Signaling Tech 2338 1:100
MEK total MEK1/2 Cell Signaling Tech 4694 1:100
DUSP4/MKP-2 Dual specificity protein phosphatase 4/MAP kinase phosphatase-2 Abcam ab216576 1:50
DUSP6/MKP-3 Dual specificity protein phosphatase 6/MAP kinase phosphatase-3 Abcam ab54940 1:50